BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Neys SFH, Hendriks RW, Corneth OBJ. Targeting Bruton's Tyrosine Kinase in Inflammatory and Autoimmune Pathologies. Front Cell Dev Biol 2021;9:668131. [PMID: 34150760 DOI: 10.3389/fcell.2021.668131] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Kohs TCL, Olson SR, Pang J, Jordan KR, Zheng TJ, Xie A, Hodovan J, Muller M, Mcarthur C, Johnson J, Sousa BB, Wallisch M, Kievit P, Aslan JE, Seixas JD, Bernardes GJL, Hinds MT, Lindner JR, Mccarty OJT, Puy C, Shatzel JJ. Ibrutinib Inhibits BMX-Dependent Endothelial VCAM-1 Expression In Vitro and Pro-Atherosclerotic Endothelial Activation and Platelet Adhesion In Vivo. Cel Mol Bioeng . [DOI: 10.1007/s12195-022-00723-1] [Reference Citation Analysis]
2 Sonowal H, Zhang H, Rice W, Howell SB. Luxeptinib disables NLRP3 inflammasome-mediated IL-1β release and pathways required for secretion of inflammatory cytokines IL-6 and TNFα. Biochem Pharmacol 2022;195:114861. [PMID: 34843717 DOI: 10.1016/j.bcp.2021.114861] [Reference Citation Analysis]
3 Liu JM, Chi J. Is COVID-19-associated cytokine storm distinct from non-COVID-19 secondary hemophagocytic lymphohistiocytosis? Exp Biol Med (Maywood). [DOI: 10.1177/15353702211068840] [Reference Citation Analysis]
4 Neys SFH, Heukels P, van Hulst JAC, Rip J, Wijsenbeek MS, Hendriks RW, Corneth OBJ. Aberrant B Cell Receptor Signaling in Naïve B Cells from Patients with Idiopathic Pulmonary Fibrosis. Cells 2021;10:1321. [PMID: 34073225 DOI: 10.3390/cells10061321] [Reference Citation Analysis]
5 Kuypers FA. Hyperinflammation, apoptosis, and organ damage. Exp Biol Med (Maywood) 2022;:15353702221090454. [PMID: 35475359 DOI: 10.1177/15353702221090454] [Reference Citation Analysis]